Lessons from familial myeloproliferative disorders

Seminars in Hematology

Volumn 42, Issue 4, 2005, Pages 266-273

  Skoda, Radek ^a,d   Prchal, Josef T ^b,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ERYTHROPOIETIN; SERINE;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT INHERITANCE; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CLONAL VARIATION; ERYTHROID PRECURSOR CELL; FAMILIAL DISEASE; FRAMESHIFT MUTATION; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; HEMATOPOIETIC STEM CELL; HERITABILITY; HUMAN; LEUKOCYTE COUNT; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; OPEN READING FRAME; PATHOPHYSIOLOGY; PENETRANCE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; THROMBOCYTHEMIA; THROMBOCYTOSIS; X CHROMOSOME INACTIVATION;

EID: 25844453885     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.08.002     Document Type: Article

References (81)

1. J.T. Prchal, W.M. Crist, E. Goldwasser, G. Perrine, J.F. Prchal Autosomal dominant polycythemia Blood 66 1985 1208 1214
2. P.D. Emanuel, C.J. Eaves, V.C. Broudy, T. Papayannopoulou, M.R. Moore, A.D. D'Andrea Familial and congenital polycythemia in three unrelated families Blood 79 1992 3019 3030
3. M.J. Fisher, J.F. Prchal, J.T. Prchal, A.D. D'Andrea Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera Blood 84 1994 1982 1991
4. E. Liu, J. Jelinek, Y.D. Pastore, Y. Guan, J.F. Prchal, J.T. Prchal Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin Blood 101 2003 3294 3301
5. J.T. Prchal Polycythemia vera and other primary polycythemias Curr Opin Hematol 12 2005 112 116
6. L. Sokol, M. Luhovy, Y. Guan, J.F. Prchal, G.L. Semenza, J.T. Prchal Primary familial polycythemia A frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin Blood 86 1995 15 22
7. E. Juvonen, E. Ikkala, F. Fyhrquist, T. Ruutu Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin Blood 78 1991 3066 3069
8. R. Kralovics, K. Indrak, T. Stopka, B.W. Berman, J.F. Prchal, J.T. Prchal Two new EPO receptor mutations Truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias Blood 90 1997 2057 2061
9. R. Kralovics, J.T. Prchal Genetic heterogeneity of primary familial and congenital polycythemia Am J Hematol 68 2001 115 121
10. R. Kralovics, L. Sokol, J.T. Prchal Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia J Clin Invest 102 1998 124 129
11. M.O. Arcasoy, X. Jiang, Z.A. Haroon Expression of erythropoietin receptor splice variants in human cancer Biochem Biophys Res Commun 307 2003 999 1007
12. G. Hess, P. Rose, H. Gamm, S. Papadileris, C. Huber, B. Seliger Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera Br J Haematol 88 1994 794 802
13. J.P. Le Couedic, M.T. Mitjavila, J.L. Villeval Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies Blood 87 1996 1502 1511
14. R. Kralovics, L. Sokol, E.H. Broxson Jr, J.T. Prchal The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia Proc Assoc Am Physicians 109 1997 580 585
15. L. Sokol, J. Prchal, J.T. Prchal Primary familial and congenital polycythaemia is a heterogeneous disorder Lancet 342 1993 115 116 (letter)
16. V. Gordeuk, J.T. Prchal Serum erythropoietin and diagnosis of polycythemic states Response to Dr. Van Maerken Haematologica 2005 ELT(05), (e-letter)
17. V.R. Gordeuk, D.W. Stockton, J.T. Prchal Congenital polycythemias/ erythrocytoses Haematologica 90 2005 109 116
18. A. de la Chapelle, A.L. Träskelin, E. Juvonen Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis Proc Natl Acad Sci USA 90 1993 4495 4499
19. M.J. Percy, M.F. McMullin, A.W. Roques Erythrocytosis due to a mutation in the erythropoietin receptor gene Br J Haematol 100 1998 407 410
20. T. Furukawa, M. Narita, M. Sakaue Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor Br J Haematol 99 1997 222 227
21. M.O. Arcasoy, B.A. Degar, K.W. Harris, B.G. Forget Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene Blood 89 1997 4628 4635
22. S.S. Watowich, X. Xie, U. Klingmuller Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state Blood 94 1999 2530 2532
23. A. Wiestner, R.J. Schlemper, A.P. van der Maas, R.C. Skoda An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia Nature Genet 18 1998 49 52
24. T. Kondo, M. Okabe, M. Sanada Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene Blood 92 1998 1091 1096
25. N. Ghilardi, R.C. Skoda A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocytosis through a mechanism of more efficient translation of TPO mRNA Blood 94 1999 1480 1482 (letter)
26. N. Ghilardi, A. Wiestner, M. Kikuchi, A. Oshaka, R.C. Skoda Hereditary thrombocythemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene Br J Haematol 107 1999 310 316
27. M.J. Jorgensen, W.H. Raskind, J.F. Wolff, H.R. Bachrach, K. Kaushansky Familial thrombocytosis associated with overproduction of thrombopoietin due to a novel splice donor site mutation Blood 92 1998 205a (suppl 1, abstr)
28. M. Cazzola, R.C. Skoda Translational pathophysiology A novel molecular mechanism of human disease Blood 95 2000 3280 3288
29. C.N. Harrison, R.E. Gale, A.C. Wiestner, R.C. Skoda, D.C. Linch The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia Br J Haematol 102 1998 1341 1343
30. H. Komatsu, J. Ding, M. Iida Familial essentian thrombocythemia associated with a dominant positive acting mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin Blood 102 2003 198 200
31. M. Onishi, A.L.F. Mui, Y. Morikawa Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer Blood 88 1996 1399 1406
32. T. Kitamura, M. Onishi, T. Yahata, Y. Kanakura, S. Asano Activating mutations of the transmembrane domain of MPL in vitro and in vivo Incorrect sequence of MPL-K, an alternative spliced form of MPL Blood 92 1998 2596 2597 (letter)
33. S. Kunishima, S. Mizuno, T. Naoe, H. Saito, T. Kamiya Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia A case study Br J Haematol 100 1998 383 386
34. A. Wiestner, S.A. Padosch, N. Ghilardi Hereditary thrombocythaemia is a genetically heterogeneous disorder exclusion of TPO and MPL in two families with hereditary thrombocythaemia Br J Haematol 110 2000 104 109
35. A.L. Taksin, J.P. Couedic, I. Dusanter-Fourt Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L Blood 93 1999 125 139
36. M. Fickers, B. Speck Thrombocythaemia Familial occurrence and transition into blastic crisis Acta Haematol 51 1974 257 265
37. P.H.T.J. Slee, J.J.E. van Everdingen, J.P.M. Geraedts, J. te Velde, G.J. den Ottolander Familial myeloproliferative disease Acta Med Scand 210 1981 321 327
38. M.E. Eyster, S.L. Saletan, E.M. Rabellino Familial essential thrombocythemia Am J Med 80 1986 497 502
39. C. Ulibarrena, A.M. Vecino, J. Odriozola, J.M. Cesar Familial essential thrombocythemia associated with von Willebrand disease Med Clin (Barc) 109 1997 237 (letter)
40. E.C. Williams, N.T. Shahidi Benign familial thrombocytosis Am J Hematol 37 1991 124 125
41. N. Cohen, D. Almoznino-Sarafian, J. Weissgarten Benign familial microcytic thrombocytosis with autosomal dominant transmission Clin Genet 52 1997 47 50
42. L. Carrel, H.F. Willard X-inactivation profile reveals extensive variability in X-linked gene expression in females Nature 434 2005 400 404
43. E. Beutler, M. Yeh, V.F. Fairbanks The normal human female as a mosaic of X-chromosome activity Studies using the gene for C-6-PD-deficiency as a marker Proc Natl Acad Sci USA 48 1962 9 16
44. B. Vogelstein, E.R. Fearon, S.R. Hamilton, A.P. Feinberg Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors Science 227 1985 642 645
45. E.R. Fearon, J.A. Winkelstein, C.I. Civin, D.M. Pardoll, B. Vogelstein Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation N Engl J Med 316 1987 427 431
46. G. Abrahamson, N.J. Fraser, J. Boyd, I. Craig, J.S. Wainscoat A highly informative X-chromosome probe, M27 beta, can be used for the determination of tumour clonality Br J Haematol 74 1990 371 372
47. D.G. Gilliland, K.L. Blanchard, J. Levy, S. Perrin, H.F. Bunn Clonality in myeloproliferative disorders Analysis by means of the polymerase chain reaction Proc Natl Acad Sci USA 88 1991 6848 6852
48. J.T. Curnutte, P.J. Hopkins, W. Kuhl, E. Beutler Studying X inactivation Lancet 339 1992 749 (letter)
49. J.T. Prchal, Y.L. Guan, J.F. Prchal, F. Barany Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis Blood 81 1993 269 271 (letter)
50. M. Luhovy, Y. Liu, M. Belickova, J.F. Prchal, J.T. Prchal A novel clonality assay based on transcriptional polymorphism of X chromosome gene p55 Biol Blood Marrow Transplant 1 1995 81 87
51. X.T. Gregg, R. Kralovics, J.T. Prchal A polymorphism of the X-linked gene IDS increases the number of females informative for transcriptional clonality assays Am J Hematol 63 2000 184 191
52. R. Kralovics, Y. Guan, J.T. Prchal Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera Exp Hematol 30 2002 229 236
53. J.F. Prchal, A.A. Axelrad Bone-marrow responses in polycythemia vera N Engl J Med 290 1974 1382 (letter)
54. S.O. Ang, H. Chen, V.R. Gordeuk Endemic polycythemia in Russia Mutation in the VHL gene Blood Cells Mol Dis 28 2002 57 62
55. R.S. Weinberg, A. Worsley, H.S. Gilbert, J. Cuttner, P.D. Berk, B.P. Alter Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia Only polycythemia vera has endogenous colonies Leuk Res 13 1989 331 338
56. R.S. Weinberg In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders Semin Hematol 34 1997 64 69
57. C.J. Eaves, A.C. Eaves Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera Blood 52 1978 1196 1210
58. J. Cashman, D. Henkelman, K. Humphries, C. Eaves, A. Eaves Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny Blood 61 1983 876 884
59. R. Kralovics, A.S. Buser, S.S. Teo Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders Blood 102 2003 1869 1871
60. C. James, V. Ugo, J.P. Le Couedic A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 2005 1144 1148
61. R.L. Levine, M. Wadleigh, J. Cools Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell 7 2005 387 397
62. R. Kralovics, F. Passamonti, A.S. Buser A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 2005 1779 1790
63. E.J. Baxter, L.M. Scott, P.J. Campbell Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 2005 1054 1061
64. J.T. Prchal Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders Semin Hematol 38 2001 10 20
65. W.D. Ratnoff, R.E. Gress The familial occurrence of polycythemia vera Report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethylene Blood 56 1980 233 236
66. M.L. Friedland, E.G. Wittels, R.J. Robinson Polycythemia vera in identical twins Am J Hematol 10 1981 101 103
67. T. Inaba, C. Shimazaki, H. Hirai Familial polycythemia vera in father and daughter Am J Hematol 51 1996 172 (letter)
68. R. Kralovics, D.W. Stockton, J.T. Prchal Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease Blood 102 2003 3793 3797
69. J.T. Prchal, J.F. Prchal, M. Belickova Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism J Exp Med 183 1996 561 567
70. R. Zhao, S. Xing, Z. Li Identification of an acquired JAK2 mutation in polycythemia vera J Biol Chem 280 2005 22788 22792
71. A.V. Jones, S. Kreil, K. Zoi Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders Blood 2005 [Epub ahead of print]
72. D.P. Steensma, G.W. Dewald, T.L. Lasho The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and the myelodysplastic syndrome Blood 106 2005 1207 1209
73. X.T. Gregg, J.T. Prchal Erythropoietin receptor mutations and human disease Semin Hematol 34 1997 70 76
74. J.T. Phelan 2nd, J.T. Prchal Clonality studies in cancer based on X chromosome inactivation phenomenon Methods Mol Med 68 2002 251 270
75. V. Najfeld, L. Montella, A. Scalise, S. Fruchtman Exploring polycythaemia vera with fluorescence in situ hybridization additional cryptic 9p is the most frequent abnormality detected Br J Haematol 119 2002 558 566
76. L. Abel, A. Alcais, A. Mallet Comparison of four sib-pair linkage methods for analyzing sibships with more than two affecteds Interest of the binomial maximum likelihood approach Genet Epidemiol 15 1998 371 390
77. M. Knapp Using exact P values to compare the power between the reconstruction-combined transmission/disequilibrium test and the sib transmission/disequilibrium test Am J Hum Genet 65 1999 1208 1210
78. S.H. Lo, X. Liu, Y. Shao A marginal likelihood model for family-based data Ann Hum Genet 67 2003 357 366
79. D. Rabinowitz Adjusting for population heterogeneity A framework for characterizing statistical information and developing efficient test statistics Genet Epidemiol 24 2003 284 290
80. M. Perez-Encinas, J.L. Bello, A. Campos, R. De Miguel, S. Tome Familial myeloproliferative syndrome Am J Hematol 46 1994 225 229
81. A. Najman, I. Chaumarel, C. Bellanne-Chantelot Phenotypic description of familial chronic myeloproliferative disorders Blood 104 2004 190a (abstr)